1,231 press releases in English indexed under travel.
Huangshan has launched a series of “Movie of Your Life” themed routes designed especially for young Korean visitors.
Last year, Stripe data shows fraud attempts against travel and leisure businesses hit a four-year high. We analyzed payment activity from more than 200,000 active travel and leisure businesses on Stripe to understand where fraud is rising, how effectively it’s being blocked, and what businesses can do in response.
- Trip.Biz launches Agent ONE, at Transform 2026 - Agent ONE is four connected, specialised agents supporting the end-to-end business travel lifecycle - Improves OBT adoption and reduces travel program leakage worldwide SINGAPORE, Sept. 17, 2026 -- Trip.Biz, the business...
GRAND RAPIDS, Mich., Sept. 17, 2026 -- Meritage Hospitality Group Inc. (OTCQX: MHGU) ("Meritage" or the "Company"), one of the nation’s largest restaurant operators, today announced that it has voluntarily filed petitions for relief under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the Western District of Michigan (the "Court"). The Company took this step to strengthen its balance sheet and establish a sustainable capital structure that positions Meritage for long-term success.
RIYADH, KSA, Sept 18, 2026 - The Riyadh Global Medical Biotechnology Summit closed today as a major success in its fourth edition and a clear statement of the scale of Saudi Arabia's ambition in biotechnology. Over three days, more than 15,000 visitors from more than 57 countries and more than 200 speakers across more than 70 sessions saw that ambition turned into more than 40 agreements, initiatives, and announcements with a combined declared value of more than SAR 5 billion (USD 1.33 billion), up from more than USD 100 million in deal value generated at the 2024 edition. Partners came from Spain, China, Japan, Germany, the United States, South Korea, Denmark, and Malaysia to join the Kingdom's leading universities, research centers, and manufacturers at the Sofitel Riyadh Hotel and Convention Centre, where more than 120 sponsors and exhibitors filled 6,000 square meters of event space and more than 180 strategic meetings took place. More than 40 agreements and announcements, initiatives, and announcements worth more than SAR 5 billion (USD 1.33 billion) delivered on every pillar of the Summit, from national strategy and regulation to investment, research readiness, and talent, with participants from more than 57 countries in Riyadh. The Summit opened on 14 September under the patronage of His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al Saud, Crown Prince and Prime Minister, and was inaugurated by His Royal Highness Prince Abdullah bin Bandar bin Abdulaziz, Minister of National Guard. His Excellency Prof. Bandar Alknawy MD , FRCPC CEO of the Ministry of National Guard Health Affairs (MNGHA) and President of King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), and King Abdullah International Medical Research Center (KAIMRC) Chairman of RGMBS, addressed the opening ceremony, describing the Summit as a platform for advancing the National Biotechnology Strategy launched by His Royal Highness the Crown Prince in January 2024, at a time of rapid and far-reaching discovery in the field. Her Royal Highness Princess Dr. Maha bint Mishari bin Abdulaziz Al Saud, Chief Executive Officer of the FII Institute, addressed the opening ceremony. Her Royal Highness highlighted the role of capital, ideas, and long-term alliances in turning scientific breakthroughs into lasting impact on humanity. She placed the human purpose of the field at the center of the Summit's work: extending not only the length of life but its quality, so that patients gain more time, and better time, with the people they love. FOUR PILLARS, ONE NATIONAL MISSION RGMBS 2026 was built on four pillars under the theme Building the Foundations of Biotechnology Excellence, with each pillar explored through scientific, panel, and executive sessions. Governmental strategies and regulatory support. KAIMRC and the Ministry of Investment launched BioSync. The one stop shop for every biotech investor, consolidating the Kingdom's entire life sciences ecosystem into a single, authoritative platform. Regulators and scientists shared the stage throughout the program, culminating in a Day Three panel on regulation as an enabling scientific tool. Investment and funding. Vaccine Industrial Company confirmed that its human vaccine manufacturing facility, a SAR 500 million investment across 42,000 square meters, is 85 percent complete and is planned to localize up to 80 percent of the Kingdom's essential vaccine needs. Sanabil Studio by Redesign Health signed with Telepath by Tahlili on AI and digital pathology, with a potential investment of USD 3 million, and the Life Sciences Innovation Forum drew applications from more than 100 companies, nominated more than 25 for investment, and engaged five investment funds willing to invest with a combined value of more than USD 120 million. Research and development readiness. King Abdullah International Medical Research Center (KAIMRC) and Thermo Fisher Scientific announced a Center of Excellence for Genomics, Proteomics, and Biobanking. The University Hospitals Program at the Council of Universities' Affairs signed with Novo Nordisk to build clinical trial capability, including earlier phase trials. KAIMRC also agreed research collaborations with Olink in proteomics, Tiziana Life Sciences in immunomodulation and neuroimmunology, and Japan's Chiyoda Corporation in plant-based peptide production for cancer treatment. King Saud University and BioMe of South Korea signed to establish a microbiome joint venture, the University of Hafr Al Batin partnered with BGI Group, and Najran University launched the Najran Genomic Biobank Initiative. Building capabilities. KAIMRC signed with Rutgers University on a summer school, master's programs, and research in artificial intelligence, and with LeapUp on training and capacity building. Princess Nourah bint Abdulrahman University and Cellenkos launched a program to develop Saudi female talent in cell and gene therapy and biomanufacturing, and SVAX and Batterjee Medical College agreed accredited biomanufacturing training with up to 350 seats per cycle. King Saud University launched four national initiatives, including an annual Saudi International Biotechnology Conference and the KSU BioHack hackathon. THREE DAYS ON THE MAIN STAGE Day One: The program opened with the National Biotechnology Strategy and a session on global partnership with Dr. Steve Yang of WuXi AppTec, Mr. Alec Reynolds of Flagship Pioneering, and Prof. Ahmed Alaskar of KAIMRC, before turning to AI in biotechnology and multi-omics, including Prof. Jin-Soo Kim of KAIST on mitochondrial DNA editing beyond CRISPR. Day Two: Investment, immunology, and bioengineering took the stage, with Mr. Kasim Kutay of Novo Holdings on investing in AI, Prof. Keith T. Flaherty, President of the American Association for Cancer Research, on cancer immunology, Astronaut Rayyanah Barnawi on the human immune system in space, and Dr. Matthew H. Porteus of Stanford University on CRISPR-engineered cell-based drugs. Day Three: The final day focused on the biotechnology workforce and regulation, a closing keynote from Dr. Hyun-Young Park, Deputy Minister of the Korea National Institute of Health, ahead of the closing ceremony. "RGMBS 2026 has shown the world what Saudi Arabia means when it says biotechnology is a national mission. We named this edition for foundations, and over three days those foundations were laid in full view: a vaccine plant nearing completion, a genomics center with Thermo Fisher, clinical trials with Novo Nordisk, and training for a new generation of Saudi scientists, each with a named partner and a defined scope. "Under the direction of our leadership and the National Biotechnology Strategy, the Kingdom is committed to leading this field for decades to come. We will measure that leadership by one standard above all: the difference it makes to the lives of patients and their families." H.E Bandar Alknawy MD , FRCPC CEO of the Ministry of National Guard Health Affairs (MNGHA) and President of KSAU-HS and KAIMRC Chairman of RGMBS . RGMBS 2026 was organized and supervised by the Ministry of National Guard, represented by its Health Affairs sector, and hosted by King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), and King Abdullah International Medical Research Center (KAIMRC), with the Ministry of Investment, Invest Saudi, and the FII Institute serving as strategic partners. The commitments made in Riyadh advance the National Biotechnology Strategy, which targets a USD 34.6 billion contribution to non-oil GDP from biotechnology by 2040, and confirm the Kingdom's place at the forefront of global biotechnology in the years ahead. About The Riyadh Global Medical Biotechnology Summit The Riyadh Global Medical Biotechnology Summit is the Kingdom of Saudi Arabia's flagship platform for medical biotechnology, convening the global scientific, investment, and policy communities in Riyadh. Organized and supervised by the Ministry of National Guard, represented by its Health Affairs sector, and hosted by KAIMRC and KSAU-HS, the Summit advances the goals of the National Biotechnology Strategy and supports the Kingdom's emergence as a global destination for health innovation. The fourth edition took place from 14 to 16 September 2026 in Riyadh. rgmbs.org FOR FURTHER INFORMATION Email: PR@legends.sa Telephone: +966 559 810 777
Adelaide, AU, Sept 17, 2026 - — Duraqex's supplied business materials cover Australian financial services representation, U.S. money services registration and securities filings. Together with accessible official records, they provide information about the named entities. Each record serves a different purpose and must be matched to specific services. Together with accessible official records, they provide information about the named entities. Each record serves a different purpose and must be matched to specific services. The project materials extend that examination to execution: which entities bear responsibility, what their authorisations cover, and what evidence supports the proposed custody and settlement capabilities. Platform Design Focuses on Capital Efficiency Across Markets Duraqex's project materials describe the digital asset market infrastructure addressing jurisdictional access differences, settlement arrangements, collateral eligibility and separately calculated margin across products or entities. These conditions affect whether capital can be deployed. An asset may have market value but remain ineligible as margin; credited funds may await settlement before further use. The proposed architecture connects market access, collateral management, execution and settlement. Project documents explain the design; availability requires product-status information and operational records. AFS Record Identifies DURAQEX PTY LTD as an Authorised Representative The supplied Australian record lists DURAQEX PTY LTD as authorised representative 001322634 of OPHELEO HOLDINGS PTY LTD, holder of Australian Financial Services (AFS) licence 224485. The document marks the representative's status as "Current." This describes a representative appointment, not an independently held AFS licence. Service coverage depends on the authorisation and licence conditions. Contracting entities, products and customer categories must correspond to those permissions. An ASIC lookup link is provided, but the status reported here remains attributed to the supplied record; live status was not independently verified. FinCEN MSB Registration Lists Reported Activities According to the official FinCEN record retrieved on September 16, 2026, Duraqex Ltd is listed under Money Services Business (MSB) registration number 31000337348934. Reported activities include foreign exchange dealing, issuing and selling money orders, and issuing traveller's checks. The U.S. Financial Crimes Enforcement Network (FinCEN) states that registrants supply the information and registration does not constitute approval or endorsement. The record should be described as MSB registration, rather than a digital asset exchange licence. The lookup confirmed the named entry and number. It does not verify custody, withdrawal capability or solvency. SEC Form D Identifies DURAQEX LTD The official SEC EDGAR Form D filing identifies DURAQEX LTD under Central Index Key (CIK) 0002144180. Form D is a notice of an exempt securities offering; the CIK identifies the filer. Readers can consult the SEC database to examine the issuer's information, identifier and securities offering disclosures, within the scope of that Form D filing. Custody, Proof of Reserves and Settlement Require Operational Evidence Business records address entity identification and reported information. Platform capabilities require operating evidence. Custody assessment considers asset-control permissions, separation of customer and corporate assets, and obligations owed to customers. Proof of Reserves should specify the assets and liabilities covered, verification methods and limitations. Execution and settlement assessment also considers test coverage, exception handling and reviewable settlement records. These are assessment criteria, not statements that Duraqex has implemented or completed those checks. Matching contracting entities, service permissions and operating records would help users and business partners assess the platform. Registration and filing records alone do not establish comprehensive authorisation, solvency or asset safety. About Duraqex Duraqex's project materials describe digital asset market infrastructure focused on capital efficiency, market access, custody and verifiable settlement. Product status and service eligibility depend on applicable authorisations and operational evidence. Sources and Publication Disclosure This company-supplied document assessment draws on project materials, the supplied Australian record and retrieved FinCEN and SEC records. It includes no account-opening, deposit or withdrawal testing or independent security audit and is not an independent platform rating. Media Contact Contact: Ravindu Wickramasuriya Email: info@desixb.com Website: https://www.desixb.com/
Surf City USA® Unites Tourism Businesses and Public Safety and City Departments to Foster a More Welcoming Destination for All HUNTINGTON BEACH, Calif., Sept. 17, 2026 -- Huntington Beach is leading the charge for accessible travel as the first destination in California to...
Realberry expands beyond Colorado with a new investment opportunity in the 297-room Hyatt Place Boston Seaport.
Germantown, Maryland--(September 17, 2026) - Airtripmaker, a fast-growing global flight booking platform, today announced an expanded focus on USA to India Flight and Canada to India Flight routes. The company has strengthened its offerings for travelers seeking Economy, Premium Economy, Business Class and First-Class flight tickets from the USA or Canada.By targeting commonly searched terms like "Business class flights" "Canada to India Business Class Flights" "Flights from US...
Studio 6 Plus Debuts in the Northeast with Five-Hotel Development Commitment from Kautilya Group
Passengers on United airplanes with Starlink-enabled seatback screens have access to live college and pro football games starting this week across 9 major sports networks Passengers on United airplanes with Starlink-enabled seatback screens have access to live college and pro football games starting this week across 9 major sports networks
Corey Kent’s sound brings together his Oklahoma roots with country soul and a rocker’s edge. Earlier this month, he brought that mix to Bloomington, Indiana, for the latest iteration of Spotify Homegrown Live, presented by Hilton, ahead of the release of his new album Heartland Rock and Roll, out September 25. It was the first... The post Corey Kent on the Song That Got Him Sent to the Principal’s Office appeared first on Spotify.